Anthony Jerant1, Paul Duberstein2, Richard L Kravitz3, Deborah M Stone4, Camille Cipri5, Peter Franks6. 1. Department of Family and Community Medicine, University of California Davis (UCD) School of Medicine, 4860 Y Street, Suite 2300, Sacramento, CA, 95817, USA. afjerant@ucdavis.edu. 2. Department of Health Behavior, Society, and Policy, Rutgers School of Public Health, 683 Hoes Lane West, Piscataway, NJ, 08854, USA. 3. Division of General Medicine, Department of Internal Medicine, UCD School of Medicine, 4150 V Street, Suite 2400, PSSB, Sacramento, CA, 95817, USA. 4. Division of Violence Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Atlanta, GA, 30341, USA. 5. Center for Healthcare Policy and Research, UCD, 2103 Stockton Blvd, Sacramento, CA, 95817, USA. 6. Department of Family and Community Medicine, University of California Davis (UCD) School of Medicine, 4860 Y Street, Suite 2300, Sacramento, CA, 95817, USA.
Abstract
PURPOSE:Middle-aged men are at high risk of suicide. While about half of those who kill themselves visit a primary care clinician (PCC) shortly before death, in current practice, few spontaneously disclose their thoughts of suicide during the visits, and PCCs seldom inquire about such thoughts. In a randomized controlled trial, we examined the effect of a tailored interactive computer program designed to encourage middle-aged men's discussion of suicide with PCCs. METHODS:We recruited men 35-74 years old reporting recent (within 4 weeks) active suicide thoughts from the panels of 42 PCCs (the unit of randomization) in eight offices within a single California health system. In the office before a visit, men viewed the intervention corresponding to their PCC's random group assignment: Men and Providers Preventing Suicide (MAPS) (20 PCCs), providing tailored multimedia promoting discussion of suicide thoughts, or control (22 PCCs), composed of a sleep hygiene video plus brief non-tailored text encouraging discussion of suicide thoughts. Logistic regressions, adjusting for patient nesting within physicians, examined MAPS' effect on patient-reported suicide discussion in the subsequent office visit. RESULTS: Sixteen of the randomized PCCs had no patients enroll in the trial. From the panels of the remaining 26 PCCs (12 MAPS, 14 control), 48 men (MAPS 21, control 27) were enrolled (a mean of 1.8 (range 1-5) per PCC), with a mean age of 55.9 years (SD 11.4). Suicide discussion was more likely among MAPS patients (15/21 [65%]) than controls (8/27 [35%]). Logistic regression showed men viewing MAPS were more likely than controls to discuss suicide with their PCC (OR 5.91, 95% CI 1.59-21.94; P = 0.008; nesting-adjusted predicted effect 71% vs. 30%). CONCLUSIONS: In addressing barriers to discussing suicide, the tailored MAPS program activated middle-aged men with active suicide thoughts to engage with PCCs around this customarily taboo topic.
RCT Entities:
PURPOSE: Middle-aged men are at high risk of suicide. While about half of those who kill themselves visit a primary care clinician (PCC) shortly before death, in current practice, few spontaneously disclose their thoughts of suicide during the visits, and PCCs seldom inquire about such thoughts. In a randomized controlled trial, we examined the effect of a tailored interactive computer program designed to encourage middle-aged men's discussion of suicide with PCCs. METHODS: We recruited men 35-74 years old reporting recent (within 4 weeks) active suicide thoughts from the panels of 42 PCCs (the unit of randomization) in eight offices within a single California health system. In the office before a visit, men viewed the intervention corresponding to their PCC's random group assignment: Men and Providers Preventing Suicide (MAPS) (20 PCCs), providing tailored multimedia promoting discussion of suicide thoughts, or control (22 PCCs), composed of a sleep hygiene video plus brief non-tailored text encouraging discussion of suicide thoughts. Logistic regressions, adjusting for patient nesting within physicians, examined MAPS' effect on patient-reported suicide discussion in the subsequent office visit. RESULTS: Sixteen of the randomized PCCs had no patients enroll in the trial. From the panels of the remaining 26 PCCs (12 MAPS, 14 control), 48 men (MAPS 21, control 27) were enrolled (a mean of 1.8 (range 1-5) per PCC), with a mean age of 55.9 years (SD 11.4). Suicide discussion was more likely among MAPS patients (15/21 [65%]) than controls (8/27 [35%]). Logistic regression showed men viewing MAPS were more likely than controls to discuss suicide with their PCC (OR 5.91, 95% CI 1.59-21.94; P = 0.008; nesting-adjusted predicted effect 71% vs. 30%). CONCLUSIONS: In addressing barriers to discussing suicide, the tailored MAPS program activated middle-aged men with active suicide thoughts to engage with PCCs around this customarily taboo topic.
Authors: Osvaldo P Almeida; Jane Pirkis; Ngaire Kerse; Moira Sim; Leon Flicker; John Snowdon; Brian Draper; Gerard Byrne; Robert Goldney; Nicola T Lautenschlager; Nigel Stocks; Helman Alfonso; Jon J Pfaff Journal: Ann Fam Med Date: 2012 Jul-Aug Impact factor: 5.166
Authors: Marsha M Linehan; Katherine Anne Comtois; Angela M Murray; Milton Z Brown; Robert J Gallop; Heidi L Heard; Kathryn E Korslund; Darren A Tutek; Sarah K Reynolds; Noam Lindenboim Journal: Arch Gen Psychiatry Date: 2006-07
Authors: Brian K Ahmedani; Gregory E Simon; Christine Stewart; Arne Beck; Beth E Waitzfelder; Rebecca Rossom; Frances Lynch; Ashli Owen-Smith; Enid M Hunkeler; Ursula Whiteside; Belinda H Operskalski; M Justin Coffey; Leif I Solberg Journal: J Gen Intern Med Date: 2014-02-25 Impact factor: 5.128
Authors: Annabel Prins; Michelle J Bovin; Derek J Smolenski; Brian P Marx; Rachel Kimerling; Michael A Jenkins-Guarnieri; Danny G Kaloupek; Paula P Schnurr; Anica Pless Kaiser; Yani E Leyva; Quyen Q Tiet Journal: J Gen Intern Med Date: 2016-05-11 Impact factor: 5.128
Authors: Gregory K Brown; Thomas Ten Have; Gregg R Henriques; Sharon X Xie; Judd E Hollander; Aaron T Beck Journal: JAMA Date: 2005-08-03 Impact factor: 56.272